Period | Weighting | Quarter | ||||||
---|---|---|---|---|---|---|---|---|
Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
GROUP ONE TRADING, L.P. | 37 | 37 | 0.00% | 0.04% | 0.18% | Q3 2013 | Q3 2022 | 37 |
SIMPLEX TRADING, LLC | 33 | 33 | 0.00% | 0.01% | 0.06% | Q4 2014 | Q4 2022 | 33 |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 17 | 17 | 0.00% | 0.00% | 0.00% | Q3 2018 | Q3 2022 | 17 |
SABBY MANAGEMENT, LLC | 9 | 3 | 0.01% | 0.55% | 1.74% | Q4 2013 | Q4 2017 | 12 |
Citadel Advisors | 11 | 11 | 0.00% | 0.00% | 0.00% | Q4 2013 | Q2 2016 | 11 |
Antara Capital LP | 6 | 1 | 0.70% | 1.17% | 2.23% | Q4 2018 | Q3 2020 | 7 |
BOOTHBAY FUND MANAGEMENT, LLC | 4 | 1 | 0.01% | 0.08% | 0.24% | Q3 2017 | Q4 2020 | 6 |
Pentwater Capital Management LP | 3 | 1 | 0.01% | 0.04% | 0.07% | Q3 2013 | Q2 2015 | 4 |
IMC-Chicago, LLC | 2 | 1 | 0.00% | 0.00% | 0.00% | Q2 2020 | Q4 2021 | 4 |
ADVENT CAPITAL MANAGEMENT /DE/ | 3 | 3 | 0.00% | 0.00% | 0.00% | Q3 2016 | Q1 2017 | 3 |
JPMORGAN CHASE & CO | 2 | 1 | 0.00% | 0.00% | 0.00% | Q1 2016 | Q3 2018 | 3 |
Iguana Healthcare Management, LLC | 2 | 2 | 1.11% | 2.26% | 3.41% | Q3 2017 | Q4 2017 | 2 |
PFM Health Sciences, LP | 2 | 2 | 0.35% | 0.41% | 0.48% | Q4 2015 | Q1 2016 | 2 |
Focused Wealth Management, Inc | 2 | 2 | 0.00% | 0.00% | 0.01% | Q3 2015 | Q4 2015 | 2 |
Partner Investment Management, L.P. | 2 | 2 | 0.32% | 0.37% | 0.42% | Q4 2015 | Q1 2016 | 2 |
JANE STREET GROUP, LLC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2022 | Q3 2022 | 2 |
Redmile Group, LLC | 1 | 1 | 0.52% | 0.85% | 1.18% | Q3 2014 | Q1 2016 | 2 |
PEAK6 Group LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2014 | Q3 2014 | 1 |
Prosight Management, LP | 1 | 1 | 1.66% | 1.66% | 1.66% | Q1 2018 | Q1 2018 | 1 |
PURA VIDA INVESTMENTS, LLC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2022 | Q2 2022 | 1 |
Mint Tower Capital Management B.V. | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2018 | Q3 2018 | 1 |
Graticule Asia Macro Advisors LLC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2017 | Q2 2017 | 1 |
This page lists all the filers that currently own CLOVIS ONCOLOGY INC or have owned CLOVIS ONCOLOGY INC in the past.